Who
Frank M. Fischer
Director
Company insider
Files Form 4 as: Director, Neuropace; Director, Nevro; Director, Tenon Medical; Director, Intralase.
In numbers
- Trades disclosed
- 66
- Buys
- 1
- Sells
- 0
- Bought
- $850K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 24 May 2006
- Last trade
- 19 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Jun 2026filed 22 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $23K1,467 at $15.63 | filing |
| 19 Jun 2026filed 22 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $23K1,467 at $15.63 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —2,890 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,368 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,368 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —2,890 at $0.00 | filing |
| 20 Mar 2026filed 23 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K1,826 at $13.00 | filing |
| 20 Mar 2026filed 23 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K1,826 at $13.00 | filing |
| 19 Dec 2025filed 23 Dec 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K1,431 at $16.59 | filing |
| 19 Sep 2025filed 22 Sep 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K2,389 at $9.94 | filing |
| 21 Jun 2025filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K2,281 at $10.41 | filing |
| 6 Jun 2025filed 9 Jun 2025 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —8,745 at $0.00 | filing |
| 21 Mar 2025filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K1,975 at $12.02 | filing |
| 21 Dec 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K2,059 at $11.53 | filing |
| 30 Sep 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K3,407 at $6.97 | filing |
| 28 Jun 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K3,141 at $7.56 | filing |
| 7 Jun 2024filed 11 Jun 2024 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —17,774 at $0.00 | filing |
| 31 Mar 2024filed 2 Apr 2024 | Nevro | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 29 Mar 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $24K1,799 at $13.20 | filing |
| 31 Dec 2023filed 3 Jan 2024 | Nevro | SEC FORM 4 Code A | —778 at $0.00 | filing |
News
Comparing CapsoVision (NASDAQ:CV) & NeuroPace (NASDAQ:NPCE)NPCE · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Frank M. Fischer; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.